Investigative Uricosuric Compound Lowers Serum Uric Acid in Patients With Gout ... - DG News

Investigative Uricosuric Compound Lowers Serum Uric Acid in Patients With Gout ... DG News Patients who did not experience a gout flare during the run-in period (colchicine) were randomised to receive RDEA594 200 mg for 4 weeks (low-dose); ... Study Confirms Febuxostat Utility in Reducing Serum Uric Acid to Goal Among ...DG News EULAR: Meta-Analysis Confirms Febuxostat Utility in Gout PatientsMedPage Today all 3 news articles »

EULAR: Canakinumab Prevents Flares in Gout Patients - MedPage Today

EULAR: Canakinumab Prevents Flares in Gout Patients MedPage Today Schlesinger noted that 44% to 45% of the patients on colchicine experienced at least one gout flare during the 16-week trial, compared with 27.3% of ... EULAR: Experimental Compound Helps Gout Patients, Lowers Uric AcidMedPage Today EULAR: New Gout Fighters in DevelopmentMedPage Today EULAR: Cherry Juice Seems to Bring Some Gout ReliefMedPage Today DG News -MedPage Today -MedPage Today all 8 news articles »

Study shows Novartis' ACZ885 prevents acute flares in gout patients - pharmabiz.com

Study shows Novartis' ACZ885 prevents acute flares in gout patients pharmabiz.com ... reduction of acute flares in gout patients initiating uric acid lowering therapy (UALT) compared to the anti-inflammatory standard of care (colchicine). ... Investigative Canakinumab Eases Pain Better Than Steroid Therapy in Patients ...DG News all 3 news articles »

EULAR: Novel Agent Eases Gout Pain - MedPage Today

EULAR: Novel Agent Eases Gout Pain MedPage Today ... trial of 191 patients ages 18 to 80 who were experiencing an acute gout flare, refractory to or contraindicated to NSAIDs and/or colchicine. ... and more »